Baclofen-Induced Coma Reversible by Dialysis in a Patient Affected by Acute Kidney Injury
DOI:
https://doi.org/10.7175/cmi.v16i1.1518Keywords:
Coma, Baclofen, Acute Kidney Injury, DialysisAbstract
Baclofen is commonly used to treat muscular spasticity and other conditions such as pain, alcohol withdrawal, and myoclonus. It is contraindicated in chronic kidney disease. As it is eliminated predominantly by the kidneys, acute kidney injury can lead to acute baclofen overdose with central nervous system affection due to drug accumulation. Currently, there is no consensus about the treatment of baclofen intoxication.
A 67-year-old woman was admitted with altered mental status and vomiting. Initially, she was unresponsive/lethargic and kept the intermittent ability of nonverbal communication gradually sliding into a comatose state with apneas. Initial neurologic and radiologic examinations ruled out a structural lesion of the central nervous system. Laboratory data showed acute kidney injury and suspected urinary tract infection with extremely high inflammation parameters. The patient had a history of multiple sclerosis and received daily oral baclofen. Baclofen-induced coma secondary to baclofen overdose caused by renal insufficiency was suspected and renal dialysis started within 24 hours. Cystoscopy and implantation of a ureteric stent were necessary because of obstructive nephropathy. During hemodialysis, the patient’s mental status steadily improved. The patient woke up and was oriented and cooperative. Both clinical and laboratory data were widely normalized within days.
Diagnosis of baclofen overdose can be challenging, but adequate supportive therapy, including hemodialysis, should be considered to reduce the length of comatose state and the risk of aspiration pneumonia.
References
Faigle JW, Keberle H. The chemistry and kinetics of Lioresal. Postgrad Med J 1972; 48: 9-13
Fox CM, Daly ML. Successful treatment of severe baclofen toxicosis initially refractory to conventional treatment. Clin Case Rep 2017; 5: 44-50; https://doi.org/10.1002/ccr3.736
Heetla HW, Proost JH, Molmans BH, et al. A pharmacokinetic-pharmacodynamic model for intrathecal baclofen in patients with severe spasticity: A PKPD model for intrathecal baclofen in humans. Br J Clin Pharmacol 2016; 81: 101-12; https://doi.org/10.1111/bcp.12781
Wuis EW, Dirks MJM, Termond EFS, et al. Plasma and urinary excretion kinetics of oral baclofen in healthy subjects. Eur J Clin Pharmacol 1989; 37: 181-4; https://doi.org/10.1007/BF00558228
Ghose K, Holmes KM, Matthewson K. Complications of baclofen overdosage. Postgrad Med J 1980; 56: 865-7; https://doi.org/10.1136/pgmj.56.662.865
Meythaler JM, Clayton W, Davis LK, et al. Orally Delivered Baclofen to Control Spastic Hypertonia in Acquired Brain Injury. J Head Trauma Rehabil 2004; 19: 101-8; https://doi.org/10.1097/00001199-200403000-00003
Brvar M, Vrtovec M, Kovač D, et al. Haemodialysis clearance of baclofen. Eur J Clin Pharmacol 2007; 63: 1143-6; https://doi.org/10.1007/s00228-007-0371-8
Ibeson E, Nwosu I, Donenfeld T, et al. Low-Dose Baclofen-Induced Encephalopathy in a Healthy Young Adult: Is Baclofen Toxicity Dose-Dependent? Cureus 2021; 13: e20499; https://doi.org/10.7759/cureus.20499
Saissy JM, Vitris M, Demazière J, et al. Flumazenil Counteracts Intrathecal Baclofen-induced Central Nervous System Depression in Tetanus. Anesthesiology 1992; 76: 1051-53; https://doi.org/10.1097/00000542-199206000-00027
Hsieh M-J, Chen S-C, Weng T-I, et al. Treating baclofen overdose by hemodialysis. Am J Emerg Med 2012; 30: 1654.e5-1654.e7; https://doi.org/10.1016/j.ajem.2011.07.013
Wu V-C, Lin S-L, Lin S-M, et al. Treatment of baclofen overdose by haemodialysis: a pharmacokinetic study. Nephrol Dial Transplant 2005; 20: 441-3; https://doi.org/10.1093/ndt/gfh297
Chen K-S, Bullard MJ, Chien Y-Y, et al. Baclofen Toxicity in Patients with Severely Impaired Renal Function. Ann Pharmacother 1997; 31: 1315-20; https://doi.org/10.1177/106002809703101108
Scott NE, Francey T, Jandrey K. Baclofen intoxication in a dog successfully treated with hemodialysis and hemoperfusion coupled with intensive supportive care. J Veter Emer Crit 2007; 17: 191-6; https://doi.org/10.1111/j.1476-4431.2006.00210.x
Koker A, Arslan G, Özden Ö, et al. An intoxication mimicking brain death: baclofen. Acta Neurol Belg 2020; 120: 33-5; https://doi.org/10.1007/s13760-018-1012-y
Müller-Schwefe G, Penn RD. Physostigmine in the treatment of intrathecal baclofen overdose: Report of three cases. J Neurosurg 1989; 71: 273-5; https://doi.org/10.3171/jns.1989.71.2.0273
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non-Commercial 4.0 Licence that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. The Publication Agreement can be downloaded here, and should be signed by the Authors and sent to the Publisher when the article has been accepted for publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- Authors are permitted to post their work online after publication (the article must link to publisher version, in html format)